Cafosa launches gum delivery excipient
Spanish ingredient supplier Cafosa has launched a new directly compressible pharmaceutical excipient for medicated chewing gums that, it claims, can boost patient compliance.
Archives for November 17, 2009
Icon plans for 35,000 sq ft site at hospital
Icon is currently planning to occupy over a third of the 100,000 sq ft redeveloped hospital in Manchester, UK, which is due to open in 2012 and will become a flagship site for the CRO.
Emergent buys Baltimore production plant
US biotech Emergent BioSolutions has bought a manufacturing facility from Maryland’s MdBio Foundation is a bid to expand its production infrastructure.
API quality enforcement in disarray; Villax
Regulatory enforcement efforts to tackle counterfeit and substandard APIs are in disarray, according to Guy Villax, CEO of Hovione, who spoke at AAPS about the scale of the problem.
GSK teams up with Nabi on NicVax
GSK has signed a $540m (€362m) licensing agreement with Nabi Biopharmaceuticals for the Phase III candidate nicotine vaccine, NicVAX.
Colorcon rolls out On-Dose ID anti-counterfeiting tech
Colorcon has met US FDA calls for PCIDs to combat fake drugs with the mark On-Dose ID labelling technology for tablet coatings.
Catalent: Irish pack plant gets ISO 15378; Swindon job cuts
US contract manufacturing organisation (CMO) Catalent’s packaging facility in Dublin, Ireland has achieved ISO 15378:2006 under the ISO’s quality scheme.
WuXi grows in Q3
WuXi PharmaTech’s operating income increased by 35 per cent in the third quarter, underpinned by strong growth in China-based laboratory services, but its manufacturing operations continue to struggle.
Lonza to manufacture GSK’s Arzerra
Lonza is manufacturing GlaxoSmithKline’s (GSK) and Genmab’s antibody Arzerra (ofatumumab), which was recently approved by the FDA, under a long-term supply deal.